-
Quantum-enhanced unsupervised image segmentation for medical images analysis
Authors:
Laia Domingo,
Mahdi Chehimi
Abstract:
Breast cancer remains the leading cause of cancer-related mortality among women worldwide, necessitating the meticulous examination of mammograms by radiologists to characterize abnormal lesions. This manual process demands high accuracy and is often time-consuming, costly, and error-prone. Automated image segmentation using artificial intelligence offers a promising alternative to streamline this…
▽ More
Breast cancer remains the leading cause of cancer-related mortality among women worldwide, necessitating the meticulous examination of mammograms by radiologists to characterize abnormal lesions. This manual process demands high accuracy and is often time-consuming, costly, and error-prone. Automated image segmentation using artificial intelligence offers a promising alternative to streamline this workflow. However, most existing methods are supervised, requiring large, expertly annotated datasets that are not always available, and they experience significant generalization issues. Thus, unsupervised learning models can be leveraged for image segmentation, but they come at a cost of reduced accuracy, or require extensive computational resourcess. In this paper, we propose the first end-to-end quantum-enhanced framework for unsupervised mammography medical images segmentation that balances between performance accuracy and computational requirements. We first introduce a quantum-inspired image representation that serves as an initial approximation of the segmentation mask. The segmentation task is then formulated as a QUBO problem, aiming to maximize the contrast between the background and the tumor region while ensuring a cohesive segmentation mask with minimal connected components. We conduct an extensive evaluation of quantum and quantum-inspired methods for image segmentation, demonstrating that quantum annealing and variational quantum circuits achieve performance comparable to classical optimization techniques. Notably, quantum annealing is shown to be an order of magnitude faster than the classical optimization method in our experiments. Our findings demonstrate that this framework achieves performance comparable to state-of-the-art supervised methods, including UNet-based architectures, offering a viable unsupervised alternative for breast cancer image segmentation.
△ Less
Submitted 22 November, 2024;
originally announced November 2024.
-
Toxicity Detection is NOT all you Need: Measuring the Gaps to Supporting Volunteer Content Moderators
Authors:
Yang Trista Cao,
Lovely-Frances Domingo,
Sarah Ann Gilbert,
Michelle Mazurek,
Katie Shilton,
Hal Daumé III
Abstract:
Extensive efforts in automated approaches for content moderation have been focused on developing models to identify toxic, offensive, and hateful content with the aim of lightening the load for moderators. Yet, it remains uncertain whether improvements on those tasks have truly addressed moderators' needs in accomplishing their work. In this paper, we surface gaps between past research efforts tha…
▽ More
Extensive efforts in automated approaches for content moderation have been focused on developing models to identify toxic, offensive, and hateful content with the aim of lightening the load for moderators. Yet, it remains uncertain whether improvements on those tasks have truly addressed moderators' needs in accomplishing their work. In this paper, we surface gaps between past research efforts that have aimed to provide automation for aspects of content moderation and the needs of volunteer content moderators, regarding identifying violations of various moderation rules. To do so, we conduct a model review on Hugging Face to reveal the availability of models to cover various moderation rules and guidelines from three exemplar forums. We further put state-of-the-art LLMs to the test, evaluating how well these models perform in flagging violations of platform rules from one particular forum. Finally, we conduct a user survey study with volunteer moderators to gain insight into their perspectives on useful moderation models. Overall, we observe a non-trivial gap, as missing developed models and LLMs exhibit moderate to low performance on a significant portion of the rules. Moderators' reports provide guides for future work on developing moderation assistant models.
△ Less
Submitted 13 November, 2024; v1 submitted 13 November, 2023;
originally announced November 2023.
-
A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery
Authors:
L. Domingo,
M. Chehimi,
S. Banerjee,
S. He Yuxun,
S. Konakanchi,
L. Ogunfowora,
S. Roy,
S. Selvaras,
M. Djukic,
C. Johnson
Abstract:
The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging…
▽ More
The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite these advances, existing models encounter issues related to convergence stability and prediction accuracy. This paper introduces a novel hybrid quantum-classical deep learning model tailored for binding affinity prediction in drug discovery. Specifically, the proposed model synergistically integrates 3D and spatial graph convolutional neural networks within an optimized quantum architecture. Simulation results demonstrate a 6% improvement in prediction accuracy relative to existing classical models, as well as a significantly more stable convergence performance compared to previous classical approaches.
△ Less
Submitted 3 September, 2024; v1 submitted 6 September, 2023;
originally announced September 2023.
-
Hybrid quantum-classical convolutional neural networks to improve molecular protein binding affinity predictions
Authors:
L. Domingo,
M. Djukic,
C. Johnson,
F. Borondo
Abstract:
One of the main challenges in drug discovery is to find molecules that bind specifically and strongly to their target protein while having minimal binding to other proteins. By predicting binding affinity, it is possible to identify the most promising candidates from a large pool of potential compounds, reducing the number of compounds that need to be tested experimentally. Recently, deep learning…
▽ More
One of the main challenges in drug discovery is to find molecules that bind specifically and strongly to their target protein while having minimal binding to other proteins. By predicting binding affinity, it is possible to identify the most promising candidates from a large pool of potential compounds, reducing the number of compounds that need to be tested experimentally. Recently, deep learning methods have shown superior performance than traditional computational methods for making accurate predictions on large datasets. However, the complexity and time-consuming nature of these methods have limited their usage and development. Quantum machine learning is an emerging technology that has the potential to improve many classical machine learning algorithms. In this work we present a hybrid quantum-classical convolutional neural network, which is able to reduce by 20% the complexity of the classical network while maintaining optimal performance in the predictions. Additionally, it results in a significant time savings of up to 40% in the training process, which means a meaningful speed up of the drug discovery process.
△ Less
Submitted 18 January, 2023; v1 submitted 16 January, 2023;
originally announced January 2023.
